Results 61 to 70 of about 51,691 (70)

Exendin-4 Reversed the PC12 Cell Damage Induced by circRNA CDR1as/miR-671/GSK3β Signaling Pathway

Journal of Molecular Neuroscience, 2020
Qiudan Chen, Meiling Lu, Sujing Qiang
exaly  

Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells

Cancer Science, 2020
Zhuo-Xun Wu, Guangsuo Wang, Jing-Quan Wang   +2 more
exaly  

miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6

European Journal of Pharmacology, 2018
Yin Yu, Zhixin Wang, Xin Wei
exaly  

The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671

European Journal of Pharmaceutical Sciences, 2000
Kevin Beaumont, Dennis A Smith, Joanne Bennett   +2 more
exaly  

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+T-lymphocyte counts

CNS Oncology, 2018
Daniela A Bota, Axel H Schönthal, Thomas C Chen   +2 more
exaly  

miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma

DNA and Cell Biology, 2019
Shitao Lu, Yu Li, Jianzhong Xu
exaly  

INHIBITORY EFFECT OF KT3-671, A NON-PEPTIDE ANGIOTENSIN SUBTYPE 1 RECEPTOR ANTAGONIST, ON SYMPATHETIC NEUROTRANSMISSION IN ISOLATED RABBIT AORTA

Pharmacological Research, 2000
Yoshinobu Takata
exaly  

Antihypertensive Effect of Chronic KT3-671, a Structurally New Nonpeptide Angiotensin AT1-Receptor Antagonist, in Stroke-Prone Spontaneously Hypertensive Rats

The Japanese Journal of Pharmacology, 1995
Kazuko Fujimoto, Takeshi Fujii
exaly  

Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis

Artificial Cells, Nanomedicine and Biotechnology, 2019
Xiao Wang
exaly  

AL0671, A new potassium channel opener, inhibits nonenzymatic glycation of protein and LDL oxidation

General Pharmacology, 1996
Sumio Matzno, Teruaki Imada, M Eda
exaly